US 8822522
Dual-acting pyrazole antihypertensive agents
granted A61PA61P13/00A61P13/12
Quick answer
US patent 8822522 (Dual-acting pyrazole antihypertensive agents) held by Theravance Biopharma R&D IP, LLC expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P13/00, A61P13/12, A61P29/00, A61P3/06